Clinical Trial Update: An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

View source ↗

Summary

This is a retrospective, multicenter observational study describing early post-authorization real-world use of dupilumab in adults with severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Status: COMPLETED